Glaukos Corp Dividends

The next dividend date for Glaukos Corp has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Glaukos Corp (GKOS)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Glaukos Corp

Country
USA
Full Time Employees
995

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. The company offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. It also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; iAccess, a precision blade; and iPRIME, a viscoelastic delivery system. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Owning Glaukos Corp Stock on the Dividend Date

If you own Glaukos Corp stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Glaukos Corp stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Glaukos Corp stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Glaukos Corp stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Glaukos Corp dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Glaukos Corp Dividends

You can contact us any time if you would like to ask questions about Glaukos Corp dividends or anything else related to the stock market.